| Add to balance / Manage account | User: | Log out |
| Prospect News home > News index > List of issuers E > Headlines for Evoke Pharma, Inc. > News item |
Evoke Pharma reports plans to conduct initial public offering of stock
Proceeds used for research and development activities for EVK-001
By Devika Patel
Knoxville, Tenn., May 24 - Evoke Pharma, Inc. will price an initial public offering of its common stock, according to a Form S-1 filed Friday with the Securities and Exchange Commission. The company expects its shares will trade on the Nasdaq under the symbol "EVOK."
The deal will have a 30-day greenshoe option.
Aegis Capital Corp. is assisting.
Proceeds will be used for research and development activities for EVK-001 and for working capital and other general corporate purposes.
The specialty pharmaceutical company is based in San Diego.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.